Unique ID issued by UMIN | UMIN000051688 |
---|---|
Receipt number | R000058595 |
Scientific Title | Preliminary study evaluating renal fibrosis with 18F-FAPI-74 PET imaging, pathology, and clinical findings |
Date of disclosure of the study information | 2023/07/24 |
Last modified on | 2024/12/18 16:20:31 |
Preliminary study evaluating renal fibrosis with 18F-FAPI-74 PET imaging, pathology, and clinical findings
FAPIKIDN1
Preliminary study evaluating renal fibrosis with 18F-FAPI-74 PET imaging, pathology, and clinical findings
FAPIKIDN1
Japan |
Kidney disease
Nephrology | Radiology | Adult |
Others
NO
To elucidate the pathogenesis of renal fibrosis by examining the relationship between renal 18F-FAPI-74 uptake, pathological indices of renal fibrosis, and related indices of renal function.
Others
Evaluating pathogenesis
Relationship between renal 18F-FAPI-74 uptake and pathologic renal fibrosis indices
1. Relationship between renal 18F-FAPI-74 uptake and FAP immunohistochemical findings
2. Relationship between renal 18F-FAPI-74 uptake and renal function (eGFRcys)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Medicine | Device,equipment |
18F-FAPI-74 PET/CT
18 | years-old | <= |
Not applicable |
Male and Female
1. Those who are 18 years of age or older at the time of consent
2. Those who have undergone or will undergo a renal biopsy for the purpose of investigation of the renal disease as part of routine medical care within 30 days of the 18F-FAPI-74 PET/CT
3. Those who have undergone or will undergo an eGFRcys (cystatin C) blood test to evaluate renal disease for the purpose of investigation of the renal disease as part of routine medical care within 30 days of the 18F-FAPI-74 PET/CT
4. Those who can obtain written informed consent
1. Those who are or may be pregnant
2. Those who have undergone or will undergo treatment for the disease between the 18F-FAPI-74 PET/CT and renal biopsy
3. Patients for whom furosemide administration is considered inappropriate by the referring physician
4. Patients for whom water intake is considered inappropriate by the referring physician
5. Those who are with severe claustrophobia
6. Those who are considered to be inappropriate to participate in this study by the principal investigator or sub-investigator
30
1st name | Tomohiko |
Middle name | |
Last name | Yamane |
Kobe City Medical Center General Hospital
Molecular Imaging Research
650-0047
Minatojima-Minamimachi 2-1-1, Chuo-ku, Kobe
078-302-4321
tomohiko_yamane@kcho.jp
1st name | Tomohiko |
Middle name | |
Last name | Yamane |
Kobe City Medical Center General Hospital
Molecular Imaging Research
650-0047
Minatojima-Minamimachi 2-1-1, Chuo-ku, Kobe
078-302-4321
https://chuo.kcho.jp/department/molecular_imaging_research/
tomohiko_yamane@kcho.jp
Kobe City Medical Center General Hospital
Katakami Foundation For Clinical Research, KBIC Research Grants-in-Aid for Clinical Research Promotion, Self-funding
Other
Kobe City Medical Center General Hospital Research Ethics Committee
Minatojima-Minamimachi 2-1-1, Chuo-ku, Kobe
078-302-5176
rinken@kcho.jp
NO
2023 | Year | 07 | Month | 24 | Day |
Unpublished
Enrolling by invitation
2023 | Year | 07 | Month | 03 | Day |
2023 | Year | 08 | Month | 10 | Day |
2023 | Year | 08 | Month | 10 | Day |
2026 | Year | 03 | Month | 31 | Day |
2023 | Year | 07 | Month | 22 | Day |
2024 | Year | 12 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058595